Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United Sts Brent Oil Fd Lp Unit
BNO
US Stock MarketDetailed Quotes
Enanta Pharmaceuticals (ENTA)
- 12.200
- -0.320-2.56%
Close Sep 18 16:00 ET
- 12.200
- 0.0000.00%
Post 19:30 ET
355.33MMarket Cap-5.04P/E (TTM)
12.605High12.190Low428.25KVolume12.490Open12.520Prev Close5.25MTurnover1.90%Turnover RatioLossP/E (Static)29.13MShares17.15052wk High3.52P/B274.73MFloat Cap7.05052wk Low--Dividend TTM22.52MShs Float127.770Highest--Div Yield TTM3.32%Range %4.090Lowest12.254Avg Price1Lot Size
Enanta Pharmaceuticals (ENTA) Key Financial Indicators
ENTA Earnings per Share (EPS)
According to the latest financial report of Enanta Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.67. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ENTA Free Cash Flow (FCF)
Interested in knowing about Enanta Pharmaceuticals's free cash flow? The latest report shows it as -9.98M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ENTA Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Enanta Pharmaceuticals shows that the company's current ratio is 3.76, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ENTA Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Enanta Pharmaceuticals, the quick ratio is 3.62, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ENTA Return on Equity (ROE)
Want to learn more about the financial health of Enanta Pharmaceuticals? The latest ROE figure is -17.92%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ENTA Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Enanta Pharmaceuticals, the total asset return on investment (ROA) is -6.38%.
Currency: USD
Quarterly
Loading...
ENTA Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Enanta Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
ENTA Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Enanta Pharmaceuticals, the net profit margin is -135.81%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm